Drug-Drug Interaction Study of TRK-100STP

NCT00719758 ↗

Phase 1 Completed 24 enrolled Astellas Pharma Inc Toray Industries, Inc · collab

RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effect of AST-120 on the PK of TRK-100STP, and to evaluate the safety and tolerability of TRK-100STP alone or in combination with AST-120

Timeline

Start: 2008-06
Primary completion: 2008-09
Completion: 2008-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Activated Charcoal	Other / unclassified	—	Oral
Subject	Beraprost	Small molecule	—	Oral

Indications

No indication recorded.